Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.

de Mattos AM, Olyaei AJ, Bennett WM.

Am J Kidney Dis. 2000 Feb;35(2):333-46. Review.

PMID:
10676738
2.

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.

Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M; European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.

Nephrol Dial Transplant. 2005 May;20(5):968-73. Epub 2005 Mar 1.

PMID:
15741208
3.
4.

Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.

Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.

Transplantation. 2007 Sep 27;84(6):706-14.

PMID:
17893603
5.

Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.

Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.

Am J Kidney Dis. 1999 Jul;34(1):69-84.

PMID:
10401019
6.

Calcineurin inhibitor nephrotoxicity.

Naesens M, Kuypers DR, Sarwal M.

Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Review.

7.

Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.

Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.

Clin Transplant. 1995 Jun;9(3 Pt 1):146-54.

PMID:
7549052
8.

Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.

Cantarovich D, Renou M, Megnigbeto A, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Karam G, Soulillou JP.

Transplantation. 2005 Jan 15;79(1):72-8.

PMID:
15714172
9.

Calcineurin inhibitor-induced renal allograft nephrotoxicity.

Krejci K, Tichy T, Bachleda P, Zadrazil J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Dec;154(4):297-306. Review.

10.

[Low-toxicity immunosuppressive therapy in renal transplant].

Scolari F, La Manna G, Comai G, Cappuccilli ML, Todeschini P, Ciavatti A, Persici E, Feliciangeli G, Stefoni S.

G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:44-8. Italian.

PMID:
17922447
11.

Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.

Jankauskiene A, Druskis V, Laurinavicius A.

Clin Nephrol. 2001 Dec;56(6):S27-9.

PMID:
11770808
12.

Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts.

Takeda A, Uchida K, Haba T, Tominaga Y, Katayama A, Yoshida A, Oikawa T, Morozumi K.

Clin Transplant. 2001;15 Suppl 5:22-9.

PMID:
11791791
13.

Chronic calcineurin inhibitor nephrotoxicity-lest we forget.

Chapman JR.

Am J Transplant. 2011 Apr;11(4):693-7. doi: 10.1111/j.1600-6143.2011.03504.x.

14.

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.

Transplantation. 1994 Jul 27;58(2):170-8.

PMID:
7518975
15.

Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.

Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.

Transplantation. 1997 Mar 27;63(6):845-8.

PMID:
9089224
16.
17.

Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, et al.

Transplantation. 1995 Jan 15;59(1):31-40.

PMID:
7530868
18.

Outcomes in kidney transplantation.

Djamali A, Premasathian N, Pirsch JD.

Semin Nephrol. 2003 May;23(3):306-16. Review.

PMID:
12838499
19.

Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.

Campistol JM, Grinyó JM.

Transplantation. 2001 Jun 15;71(11 Suppl):SS42-51. Review.

PMID:
11583488
20.

Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.

Nielsen FT, Ottosen P, Starklint H, Dieperink H.

Nephrol Dial Transplant. 2003 Mar;18(3):491-6.

PMID:
12584269

Supplemental Content

Support Center